These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 9086359

  • 1. [Amyotrophic lateral sclerosis].
    Moriwaka F.
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):21-5. PubMed ID: 9086359
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical trials of ultra-high-dose methylcobalamin in ALS].
    Izumi Y, Kaji R.
    Brain Nerve; 2007 Oct; 59(10):1141-7. PubMed ID: 17969354
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Motor neuron disease.
    Jackson CE, Rosenfeld J.
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):335-52, ix-x. PubMed ID: 11345011
    [Abstract] [Full Text] [Related]

  • 10. [ALS and neurotrophic factors--HGF as a novel neurotrophic and neuroregenerative factor].
    Funakoshi H, Ohya W, Kadoyama K, Nakamura T.
    Brain Nerve; 2007 Oct; 59(10):1195-202. PubMed ID: 17969361
    [Abstract] [Full Text] [Related]

  • 11. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
    Vanoni C, Massari S, Losa M, Carrega P, Perego C, Conforti L, Pietrini G.
    J Cell Sci; 2004 Oct 15; 117(Pt 22):5417-26. PubMed ID: 15466883
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Riluzole for amyotrophic lateral sclerosis.
    Med Lett Drugs Ther; 1995 Dec 08; 37(963):113-4. PubMed ID: 7500908
    [No Abstract] [Full Text] [Related]

  • 14. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene.
    Cudkowicz ME, McKenna-Yasek D, Chen C, Hedley-Whyte ET, Brown RH.
    Ann Neurol; 1998 Jun 08; 43(6):703-10. PubMed ID: 9629839
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rilutek (Riluzole) may extend survival in amyotrophic lateral sclerosis.
    J Neurosci Nurs; 1996 Aug 08; 28(4):275. PubMed ID: 8880606
    [No Abstract] [Full Text] [Related]

  • 17. Amyotrophic lateral sclerosis is a multifactorial disease.
    Eisen A.
    Muscle Nerve; 1995 Jul 08; 18(7):741-52. PubMed ID: 7783764
    [Abstract] [Full Text] [Related]

  • 18. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
    Andreadou E, Kapaki E, Kokotis P, Paraskevas GP, Katsaros N, Libitaki G, Zis V, Sfagos C, Vassilopoulos D.
    Clin Neurol Neurosurg; 2008 Mar 08; 110(3):222-6. PubMed ID: 18055102
    [Abstract] [Full Text] [Related]

  • 19. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
    Morrison BM, Morrison JH, Gordon JW.
    J Exp Zool; 2008 Mar 08; 282(1-2):32-47. PubMed ID: 9723164
    [Abstract] [Full Text] [Related]

  • 20. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
    Yanagisawa N, Shindo M.
    Rinsho Shinkeigaku; 1996 Dec 08; 36(12):1329-30. PubMed ID: 9128396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.